Resumo

OLAYA-VARGAS, Alberto et al. Evaluation of treatment with VAMP plus involved-field radiation in Mexican pediatric patients with early-stage Hodgkin lymphoma. Bol. Med. Hosp. Infant. Mex. [online]. 2009, vol.66, n.1, pp.60-67. ISSN 1665-1146.

Introduction. Purpose: To evaluate outcome and assess toxicity of patients with early-stage Hodgkin lymphoma treated with VAMP and low-dose involved-field radiation. Methods. Patients with clinical favorable stages Hodgkin lymphoma were treated with 4 cycles of VAMP (vinblastine 6 mg/m²sc, doxorrubicyn 25 mg/m²sc, methotrexate 20 mg/ m²sc, and prednisone 40 mg/m²sc) administrated on day 1 and day 15. And 21.6 Gy involvedfied radiation. The over-all survival was estimated using Kaplan-Meier and Cox methods. Results. 17 patients were included, the median age was 7 years. Two patients present progressive disease at 4 and 16 months respectively. The overall survival were 94.12% with follow-up of 66 months (IC 95%), the event-free survival were 88.24% with follow up of 63 months (IC 95%). Conclusions. The combined modality therapy with chemotherapy and involved-field radiation (21.6 Gy) shows a better overall survival. The radiation toxicity was elevated, for that reason we must try to reduce the dose of radiotherapy at 15 Gy in patients with complete response to treatment.

Palavras-chave : Hodgkin lymphoma; VAMP; involved-field radiation.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )